CRISPR Therapeutics AG - Common Shares (CRSP) by event type
CRSP moves most on analyst upgrades — a median of +0.92% at 30 minutes across 17 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the CRSP overview →
How CRSP reacts across 6 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 152 of 2,717 | 17 | +0.92% | 65% | +1.58% |
| Analyst downgrades 1,699 of 2,603 | 10 | -0.10% | 10% | +0.37% |
| Coverage initiations 250 of 2,283 | 16 | +0.72% | 63% | +0.58% |
| Rating reiterations 1,583 of 3,522 | 162 | 0.00% | 49% | +0.45% |
| Price-target raises 105 of 1,790 | 21 | +0.34% | 62% | +1.25% |
| Price-target cuts 1,226 of 1,527 | 32 | -0.18% | 44% | +0.10% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one.
That’s how CRSP usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · Price-target cuts → · CRSP overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Merus N.V. - Common Shares (MRUS) | 292 | +0.03% | 54% |
| Trinity Biotech plc - American Depositary Shares (TRIB) | 292 | -0.13% | 44% |
| Seres Therapeutics, Inc. (MCRB) | 290 | -0.23% | 46% |
| Accuray Incorporated (ARAY) | 288 | 0.00% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.